TR200606411T1 - Vajinite karşı bir triazol içeren bileşimler. - Google Patents

Vajinite karşı bir triazol içeren bileşimler.

Info

Publication number
TR200606411T1
TR200606411T1 TR2006/06411T TR200606411T TR200606411T1 TR 200606411 T1 TR200606411 T1 TR 200606411T1 TR 2006/06411 T TR2006/06411 T TR 2006/06411T TR 200606411 T TR200606411 T TR 200606411T TR 200606411 T1 TR200606411 T1 TR 200606411T1
Authority
TR
Turkey
Prior art keywords
vaginitis
compositions
active ingredients
compound effective
effective against
Prior art date
Application number
TR2006/06411T
Other languages
English (en)
Inventor
Embi̇l Koral
Baktir Gül
Original Assignee
Edko Trading And Representation Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edko Trading And Representation Co. Ltd. filed Critical Edko Trading And Representation Co. Ltd.
Publication of TR200606411T1 publication Critical patent/TR200606411T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş vajinal enfeksiyonların, örneğin vajinitin tedavisinde topikal uygulamaya yönelik farmasötik bileşimler sunmaktadır. Bu bileşimler (i) Candidiaalbicans 'a karşı etkili en az bir triazol bileşiği, tercihen ayrıca albicans olmayan Candida türlerinin birine veya daha fazlasına karşı da etkili olan bu tür en az bir bileşik, ve (ü) vajinite karşı en az bir ek ilaç, tercihen antifungal, antiprotozoal ve/veya antibakteriyel bir madde içermektedir. Tercih edilen bileşimler etken maddeler olarak tinidazol ve/veya tiokonazolle kombine olarak terkonazol içerir. Başka bir yönüyle buluşa uygun bileşimler ayrıca vajina mukozasına yapışmayı teşvik etmek için biyolojik yapışkan bir madde, örneğin bir mukoza yapışkanı içerir. Biyolojik yapışkanın kullanılması ayrıca etken maddelerin kontrollü, örneğin hızlı ve/veya geciktirilmiş (sürekli) şahmını da temin edebilir.
TR2006/06411T 2004-03-10 2004-09-17 Vajinite karşı bir triazol içeren bileşimler. TR200606411T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0405406.0A GB0405406D0 (en) 2004-03-10 2004-03-10 Anti-vaginitis compositions

Publications (1)

Publication Number Publication Date
TR200606411T1 true TR200606411T1 (tr) 2007-01-22

Family

ID=32117416

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/06411T TR200606411T1 (tr) 2004-03-10 2004-09-17 Vajinite karşı bir triazol içeren bileşimler.

Country Status (7)

Country Link
CN (1) CN1960763A (tr)
BR (1) BRPI0418623A (tr)
EA (1) EA011952B1 (tr)
GB (1) GB0405406D0 (tr)
PL (1) PL380815A1 (tr)
TR (1) TR200606411T1 (tr)
WO (1) WO2005087270A1 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
AU2004274000B2 (en) 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
CA2617106A1 (en) * 2005-08-12 2007-02-22 Drugtech Corporation Estrogen compositions and therapeutic methods of use thereof
WO2007079391A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
CN101374501A (zh) * 2006-01-05 2009-02-25 药物技术公司 组合物及其使用方法
US9211286B2 (en) * 2006-09-12 2015-12-15 Curatek Pharmaceuticals Holding, Inc. Terconazole composition and method
US10758630B2 (en) 2010-08-13 2020-09-01 The Johns Hopkins University Topical compositions and methods of detection and treatment
CN102091097B (zh) * 2011-01-28 2013-04-03 武汉耦合医学科技有限责任公司 一种免冲洗产妇会阴医疗护理凝胶及其制备方法
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
WO2014026707A1 (en) 2012-08-13 2014-02-20 Edko Pazarlama Tanitim Ticaret Limited Sirketi Anti-vaginitis compositions with improved release and adherence
WO2014027006A1 (en) 2012-08-13 2014-02-20 Edko Pazarlama Tanitim Ticaret Limited Sirketi Bioadhesive formulations for use in drug delivery
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US9446024B2 (en) * 2013-06-25 2016-09-20 UNIVERSITé LAVAL Formulations for the treatment of vaginal disorders
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
WO2021154188A1 (en) * 2020-01-31 2021-08-05 Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi Pharmaceutical composition suitable for vaginal delivery
US11529346B2 (en) * 2020-06-18 2022-12-20 National Medical Supply, LLC Vaginal gel
CN111759840B (zh) * 2020-07-20 2021-05-11 温州市人民医院 一种防治心肌缺血的药物组合物及其制备方法和用途
CN112190541A (zh) * 2020-09-27 2021-01-08 安婕妤化妆品科技股份有限公司 一种私密护理凝胶产品
CN112245657B (zh) * 2020-10-19 2022-07-01 合肥中科智远生物科技有限公司 一种低放热抗菌骨水泥及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
CA2177682C (en) * 1993-12-23 1999-12-28 Sekhar Mitra Antimicrobial wipe compositions
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US20030073646A1 (en) * 1997-01-22 2003-04-17 Marton Milankovits Pharmaceutical compositions primarily for the treatment of genitourinary infections
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses

Also Published As

Publication number Publication date
GB0405406D0 (en) 2004-04-21
EA011952B1 (ru) 2009-06-30
PL380815A1 (pl) 2007-03-19
EA200601647A1 (ru) 2007-02-27
BRPI0418623A (pt) 2007-05-29
WO2005087270A1 (en) 2005-09-22
CN1960763A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
TR200606411T1 (tr) Vajinite karşı bir triazol içeren bileşimler.
JP6382798B2 (ja) 局所非水性医薬製剤
AR050838A1 (es) Formulacion farmaceutica. para el tratamiento de una infeccion optica
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
WO2003086408A8 (en) Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
ATE384534T1 (de) Lösung zur nagel-verwendung
BR0012046A (pt) Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
WO2007131253A3 (de) Verwendung von kombinationspräparaten, umfassend antimykotika
MX9505182A (es) Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p.
WO2005018544A8 (en) Therapy-enhancing glucan
WO2006048747A8 (en) Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002036129A3 (de) Topische behandlung von mastalgie mit aromatase-hemmern, wie androstendion
WO2002102311A3 (en) Nanoparticles for treating targeted tissues and cells
WO2001066551A8 (en) Azole compounds as therapeutic agents for fungal infections
WO2003101382A3 (en) Compounds useful in the treatment of anthrax and inhibiting lethal factor
WO2004071402A3 (en) STABLE PHARMACEUTICAL DOSAGE FORM COMPRISING HMG-CoA REDUCTASE INHIBITOR
WO2003086271A3 (en) Azole derivatives as antifungal agents
MA31678B1 (fr) Composition therapeutique aromatisee a base d'argile
ATE553116T1 (de) Metall bindende verbindungen und ihre verwendungen
MD1812B1 (en) Copper complexes as bacteria and fungi inhibitors
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2002055022A3 (en) Active metabolite of antifungal compound
WO2007076053A8 (en) Stable s-nitrosothiol formulations